Dr. Alan Fozailoff, MD

Dr. Fozailoff practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Fozailoff's NPI, 1053331595, was assigned on July 20, 2006. Dr. Fozailoff graduated from Albert Einstein College of Medicine in 1995. Dr. Fozailoff holds California license A76164.

Dr. Fozailoff's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Fozailoff's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Fozailoff is also affiliated with Cedars-Sinai Medical Center. Dmand AI also links Dr. Fozailoff to 2 more hospitals, 2 dialysis centers and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fozailoff practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Fozailoff's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Fozailoff is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Fozailoff's licenses on file in 3 states: California, Massachusetts and Hawaii.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, kidney cysts, kidney disease and parathyroid gland disorder among the conditions Dr. Fozailoff treats.

CMS data shows 4,025 Medicare services from Dr. Fozailoff across 10 procedure codes in 2024, for 840 Medicare patients. Medicare paid $445,633 for them.

CMS counts 840 Medicare patients who saw Dr. Fozailoff in 2024. The largest group is 75 to 84, with 307 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 51% are also on Medicaid. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fozailoff's median patient age at 76, with 41% women.

In 2024, Dr. Fozailoff wrote 1,794 Medicare Part D claims for 190 patients. 82% of them were for generic drugs. CMS names the drug for 1,535 of them, across 50 drugs with 11 or more claims each, at $271,985 in total drug cost. In 2023, CMS named 1,480 claims across 50 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Fozailoff for performance year 2024, reported as part of a group. Dr. Fozailoff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fozailoff as offering telehealth.

Dmand AI links 2 papers to Dr. Fozailoff. The most frequent topics are Hypertension. Dr. Fozailoff has published most often in J Clin Pharmacol. Dr. Fozailoff's most frequent co-authors are Cherry Lin, MD and Sundeep Mediratta, MD.

CMS Open Payments shows 54 general payments to Dr. Fozailoff from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Amgen Inc. paid the most, $558.

Dr. Fozailoff graduated from Albert Einstein College of Medicine in 1995.

Dr. Fozailoff is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.